Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satoshi Motoya

Showing results (71-80 of 89) with videos related to

Pageof 9
Sort By:
Intestinal Research|January 16, 2025
Factors affecting 1-year persistence with vedolizumab for ulcerative colitis: a multicenter, retrospective real-world studyTaku Kobayashi, Tadakazu Hisamatsu, Satoshi Motoya, et al.
Digestion|December 17, 2018
Questionnaire-Based Survey on Management of Ulcerative Colitis-Associated Cancer in East Asian CountriesSatoru Yamaguchi, Kinro Sasaki, Hiroyuki Kato, et al.
Journal of Gastroenterology and Hepatology|May 15, 2025
Real-World Effectiveness and Safety of Vedolizumab in Patients ≥ 70 Versus < 70 Years With Ulcerative Colitis: Multicenter Retrospective StudyTadakazu Hisamatsu, Taku Kobayashi, Satoshi Motoya, et al.
Digestion|July 27, 2023
Current Status of Diagnosis and Treatment of Colorectal Cancer in Asian Countries: A Questionnaire SurveyHidenori Tanaka, Shiro Oka, Akiko Shiotani, et al.
The American Journal of Gastroenterology|September 3, 2009
An open-label prospective randomized multicenter study shows very rapid remission of ulcerative colitis by intensive granulocyte and monocyte adsorptive apheresis as compared with routine weekly treatmentAtsushi Sakuraba, Satoshi Motoya, Kenji Watanabe, et al.
Gastroenterology|December 26, 2012
A genome-wide association study identifies 2 susceptibility Loci for Crohn's disease in a Japanese populationKeiko Yamazaki, Junji Umeno, Atsushi Takahashi, et al.
Intestinal Research|May 11, 2018
Predicting outcomes to optimize disease management in inflammatory bowel disease in Japan: their differences and similarities to Western countriesTaku Kobayashi, Tadakazu Hisamatsu, Yasuo Suzuki, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 9, 2019
Significance of Conducting 2 Types of Fecal Tests in Patients With Ulcerative ColitisMakoto Naganuma, Taku Kobayashi, Masanao Nasuno, et al.
BMC Gastroenterology|November 21, 2015
An open-label prospective randomized multicenter study of intensive versus weekly granulocyte and monocyte apheresis in active crohn's diseaseNaoki Yoshimura, Yoko Yokoyama, Katsuyoshi Matsuoka, et al.
Journal of Gastroenterology|February 12, 2018
Evidence-based clinical practice guidelines for inflammatory bowel diseaseKatsuyoshi Matsuoka, Taku Kobayashi, Fumiaki Ueno, et al.
Pageof 9

Showing results (71-80 of 89) with videos related to

Sort By:
Pageof 9
Intestinal Research|January 16, 2025
Factors affecting 1-year persistence with vedolizumab for ulcerative colitis: a multicenter, retrospective real-world studyTaku Kobayashi, Tadakazu Hisamatsu, Satoshi Motoya, et al.
Digestion|December 17, 2018
Questionnaire-Based Survey on Management of Ulcerative Colitis-Associated Cancer in East Asian CountriesSatoru Yamaguchi, Kinro Sasaki, Hiroyuki Kato, et al.
Journal of Gastroenterology and Hepatology|May 15, 2025
Real-World Effectiveness and Safety of Vedolizumab in Patients ≥ 70 Versus < 70 Years With Ulcerative Colitis: Multicenter Retrospective StudyTadakazu Hisamatsu, Taku Kobayashi, Satoshi Motoya, et al.
Digestion|July 27, 2023
Current Status of Diagnosis and Treatment of Colorectal Cancer in Asian Countries: A Questionnaire SurveyHidenori Tanaka, Shiro Oka, Akiko Shiotani, et al.
The American Journal of Gastroenterology|September 3, 2009
An open-label prospective randomized multicenter study shows very rapid remission of ulcerative colitis by intensive granulocyte and monocyte adsorptive apheresis as compared with routine weekly treatmentAtsushi Sakuraba, Satoshi Motoya, Kenji Watanabe, et al.
Gastroenterology|December 26, 2012
A genome-wide association study identifies 2 susceptibility Loci for Crohn's disease in a Japanese populationKeiko Yamazaki, Junji Umeno, Atsushi Takahashi, et al.
Intestinal Research|May 11, 2018
Predicting outcomes to optimize disease management in inflammatory bowel disease in Japan: their differences and similarities to Western countriesTaku Kobayashi, Tadakazu Hisamatsu, Yasuo Suzuki, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 9, 2019
Significance of Conducting 2 Types of Fecal Tests in Patients With Ulcerative ColitisMakoto Naganuma, Taku Kobayashi, Masanao Nasuno, et al.
BMC Gastroenterology|November 21, 2015
An open-label prospective randomized multicenter study of intensive versus weekly granulocyte and monocyte apheresis in active crohn's diseaseNaoki Yoshimura, Yoko Yokoyama, Katsuyoshi Matsuoka, et al.
Journal of Gastroenterology|February 12, 2018
Evidence-based clinical practice guidelines for inflammatory bowel diseaseKatsuyoshi Matsuoka, Taku Kobayashi, Fumiaki Ueno, et al.
Pageof 9